The Ministry of Public Health explained that the discriminatory measures taken by the Public Prosecution regarding the seizure of medicines in the Lebanese market were based on a referral and a letter from the Minister of Health, Rakan Nasser Al-Din, following an internal investigation conducted by the Ministry. The Ministry indicated, in a statement, that the investigation showed that the medicines seized by the security forces on the basis of a signal from the discriminatory Public Prosecutor, a ministerial decision had previously been issued to cancel them because they did not meet the conditions required for their use and circulation in the Lebanese market. Nasser Al-Din announced that he is in the process of making a decision to re-study and evaluate all biosimilar medicines (Biosimilar) present in the Lebanese market, and review their files to ensure their compliance with the standards and conditions approved in accordance with the latest rules of the World Health Organization, in order to preserve the safety of patients and ensure their access to safe and effective medicines. The Ministry stressed that its handling of this file is based on scientific and legal foundations, away from political considerations, calling on the media to be accurate in conveying information and avoid unscientific allegations. She stressed continued coordination with the judicial and security agencies in a way that preserves public health and the interest of citizens.